Published in Curr Hypertens Rev on January 01, 2015
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell (2007) 30.22
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science (2008) 13.79
Molecular mechanisms of long noncoding RNAs. Mol Cell (2011) 11.44
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
Long noncoding RNAs and human disease. Trends Cell Biol (2011) 7.59
Modular regulatory principles of large non-coding RNAs. Nature (2012) 7.42
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol (2012) 5.12
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal (2010) 4.77
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol (2007) 4.65
Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res (2012) 4.06
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet (2009) 3.81
Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A (2014) 3.35
Transcribed dark matter: meaning or myth? Hum Mol Genet (2010) 2.87
Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation (2011) 2.60
Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation (2011) 2.52
Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med (2011) 2.18
Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet (2011) 2.14
Long noncoding RNAs in patients with acute myocardial infarction. Circ Res (2014) 2.02
Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension (2010) 1.94
Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension (2012) 1.92
The central role of RNA in human development and cognition. FEBS Lett (2011) 1.92
Fewer genes, more noncoding RNA. Science (2005) 1.84
Long noncoding RNAs in cardiac development and pathophysiology. Circ Res (2012) 1.72
Role of microRNAs in kidney homeostasis and disease. Kidney Int (2012) 1.72
Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci (2012) 1.63
Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci (2013) 1.61
Differential microRNA expression profiles in peripheral arterial disease. Circ Cardiovasc Genet (2013) 1.59
Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens (2009) 1.59
Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Nucleic Acids Res (2012) 1.58
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest (2013) 1.55
Circulating microRNAs: novel biomarkers for cardiovascular diseases. J Mol Med (Berl) (2011) 1.54
On the classification of long non-coding RNAs. RNA Biol (2013) 1.53
MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics (2010) 1.48
Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol (2012) 1.48
A common genetic variant in the 3'-UTR of vacuolar H+-ATPase ATP6V0A1 creates a micro-RNA motif to alter chromogranin A processing and hypertension risk. Circ Cardiovasc Genet (2011) 1.47
MicroRNAs: role in cardiovascular biology and disease. Clin Sci (Lond) (2008) 1.44
Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention. EuroIntervention (2013) 1.42
MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol (2009) 1.41
Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta (2012) 1.39
Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension (2011) 1.36
Pex11p plays a primary role in medium-chain fatty acid oxidation, a process that affects peroxisome number and size in Saccharomyces cerevisiae. J Cell Biol (2000) 1.33
Micromanaging vascular biology: tiny microRNAs play big band. J Vasc Res (2009) 1.31
Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab (2012) 1.31
Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res (2013) 1.30
Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension (2010) 1.28
Noncoding RNA transcription beyond annotated genes. Curr Opin Genet Dev (2007) 1.25
Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript. J Biol Chem (2004) 1.22
Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest (2013) 1.17
Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep (2013) 1.17
Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation (2013) 1.14
Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens Rep (2012) 1.13
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med (2013) 1.12
The role of microRNAs in arterial remodelling. Thromb Haemost (2012) 1.12
Mammalian proapoptotic factor ChaC1 and its homologues function as γ-glutamyl cyclotransferases acting specifically on glutathione. EMBO Rep (2012) 1.12
MicroRNAs in vascular disease. J Cardiovasc Pharmacol (2011) 1.11
Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J Clin Invest (2011) 1.10
Oxidative stress and microRNAs in vascular diseases. Int J Mol Sci (2013) 1.10
miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol (2011) 1.10
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail (2013) 1.09
Regulation of myocardial fibrosis by MicroRNAs. J Cardiovasc Pharmacol (2010) 1.08
MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol (2012) 1.07
MicroRNAs in vascular biology and vascular disease. J Cardiovasc Transl Res (2010) 1.07
Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II. Mol Cell Biol (2005) 1.06
Long noncoding RNA: a new player of heart failure? J Cardiovasc Transl Res (2013) 1.05
Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16, -21, and -126. Hypertension (2012) 1.05
Phosphorylation-dependent activation of peroxisome proliferator protein PEX11 controls peroxisome abundance. J Biol Chem (2009) 1.03
SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens (2011) 1.03
Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One (2012) 1.03
MicroRNA-modulated targeting of vascular smooth muscle cells. J Clin Invest (2009) 1.02
Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens (2010) 1.02
MicroRNAs and beyond: the heart reveals its treasures. Hypertension (2009) 1.01
microRNAs in stroke pathogenesis. Curr Mol Med (2011) 1.00
MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep (2012) 1.00
MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens (2010) 1.00
Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans. BMC Neurol (2013) 0.99
Relations between circulating microRNAs and atrial fibrillation: data from the Framingham Offspring Study. Heart Rhythm (2014) 0.99
MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochem Biophys Res Commun (2009) 0.99
miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn (2011) 0.98
MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens (2011) 0.98
MicroRNAs are involved in end-organ damage during hypertension. Hypertension (2012) 0.97
MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts. Biochem Biophys Res Commun (2010) 0.97
Blood microRNAs in low or no risk ischemic stroke patients. Int J Mol Sci (2013) 0.95
MicroRNAs in kidney disease: an emerging understanding. Am J Kidney Dis (2012) 0.95
Genetics and epigenetics of arrhythmia and heart failure. Front Genet (2013) 0.94
Emerging trends of long non-coding RNAs in gene activation. FEBS J (2013) 0.94
Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol Res (2013) 0.94
Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts. J Physiol Sci (2012) 0.94
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets (2013) 0.93
Circulating microRNAs as biomarkers of acute stroke. Int J Mol Sci (2014) 0.92
Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens (2013) 0.92
Circulating microRNAs serve as novel biological markers for intracranial aneurysms. J Am Heart Assoc (2014) 0.91
The emerging role of microRNA in stroke. Curr Top Med Chem (2013) 0.91
Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells. Endocrinology (2008) 0.90
MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage. J Am Soc Hypertens (2014) 0.90
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation. Front Genet (2014) 0.89
MicroRNAs mediate metabolic stresses and angiogenesis. Cell Mol Life Sci (2011) 0.88